RegMed Daily, Closing Bell, 9/30/11, my end of the month and quarter RANT
End of Day, Cause and Effect … hoping, no praying for a GOOD Q4/11 Read more…
End of Day, Cause and Effect … hoping, no praying for a GOOD Q4/11 Read more…
The BOD has appointed John A. Scarlett, MD as its CEO and to its BOD. Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
End of Day, Cause and Effect … Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
ATHX plans for a P2 ischemic stroke clinical trial that’s estimated to involve about 140 patients Read more…
Good morning! Here’s what you … might need to know to start the day… Read more…
End of Day, Cause and Effect … Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…

Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.